September 26, 2012 (Ottawa, Ontario) — Primary-care practitioners may be putting the lives of patients with prosthetic heart valves at risk by switching their anticoagulation from warfarin to newer ...
Silver Spring, MD - Bleeding rates associated with the use of dabigatran etexilate (Pradaxa, Boehringer Ingelheim) appear to be no higher than bleeding rates associated with warfarin when used as an ...
Pradaxa label updated with contraindication The anticoagulant dabigatran etexilate mesylate should not be used in patients with mechanical prosthetic heart valves, the FDA warns. HealthDay News – The ...
Dallas, Nov 18 (Reuters) - An experimental antidote to the widely used blood clot preventer Pradaxa worked immediately and completely in an early-stage trial among healthy volunteers, raising hopes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results